Home / Central Data Catalog / FRESH-PEF3301-EN
central

Relationship between insulin sensitivity and cardiovascular disease

Austria, Denmark, Finland...and 12 more, 2002 - 2007
Reference ID
FRESH-PEF3301-en
Producer(s)
Beverley;BALKAU
Metadata
DDI/XML JSON
Study website Interactive tools
Created on
Feb 18, 2026
Last modified
Feb 18, 2026
Page views
35
  • Identification
  • Scope
  • Coverage
  • Producers and sponsors
  • Study authorization
  • Sampling
  • Survey instrument
  • Data collection
  • Study activities
  • Data Access

    • Identification

    Survey ID number

    FRESH-PEF3301-en
    Title

    Relationship between insulin sensitivity and cardiovascular disease
    Abbreviation or Acronym

    EGIR-RISC
    Country
    Name Country code
    Austria at
    Denmark dk
    Finland fi
    France fr
    Germany de
    Greece gr
    Netherlands nl
    Ireland ie
    Italy it
    Sweden se
    Spain es
    Switzerland ch
    United kingdom gb
    Serbia rs
    Montenegro me
    Kind of Data

    ['Clinical data','Paraclinical data (non-biological)','Paraclinical data (non-biological) : Imaging','Biological data','Participant-reported health data']
    Unit of Analysis

    Individuals

    Scope

    Topics
    Topic Vocabulary
    Endocrinology health theme
    Behavioral determinants health determinant
    Socio-demographic and economic determinants health determinant
    Behavioral determinants: Addiction health determinant

    Coverage

    Universe

    {"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"Aged between 30 and 60 years - Good general health condition - No symptoms of cardiovascular diseases - blood pressure inferior to 170/90 mm Hg - Total cholesterol inferior to 7,8 mmol/l - Triglycerides levels inferior to 4,6 mmol/l - Plasma glucose level (on an empty stomach and 2 hours after an oral glucose control) inferior to 7,0/11,1 mmol/l - No treatment related to diabetes, hypertension or lipid disorders","clusion_E":""}

    Producers and sponsors

    Primary investigators
    Name
    Beverley;BALKAU
    Producers
    Name Role
    CTRE RECHERCHE NUTRITION HUMAINE RHONE-ALPES (CRNH RHONE-ALPES) sponsor
    Funding Agency/Sponsor
    Name
    EUROPEAN COMMISSION RESEARCH
    ASTRAZENECA (FRANCE)
    MERCK SANTE

    Study authorization

    Agency
    Agency name
    CNIL
    ANSM
    CPP

    Sampling

    Sample frame

    Unit Type

    ['Through organizations (health services or institutions, schools, businesses, etc.)']
    Sampling Procedure

    ['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']

    Survey instrument

    Questionnaires

    Access on specific project only
    Methodology notes

    Observational Study

    Data collection

    Dates of Data Collection
    Start End
    2002-01-01 2007-01-01
    Mode of data collection
    • {"concept":{"vocabURI":"Interview","vocab":"CESSDA"},"value":"Interview with the participant (including clinical)"}

    Study activities

    Study activities
    Type
    primary evaluation
    Description
    Health event/morbidity Health event/mortality

    Data Access

    Access conditions

    For data access, please submit a written request to the "project management board".
    Availability Status

    {"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}
    Back to Catalog